申请人:NIPPON SHINYAKU CO., LTD.
公开号:US20170320903A1
公开(公告)日:2017-11-09
The present invention provides a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.
The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene.